No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. [electronic resource] - Gynecologic oncology 05 2016 - 386-401 p. digital

Publication Type: Journal Article; Review

1095-6859

10.1016/j.ygyno.2015.04.034 doi


Breast Neoplasms--enzymology
Carcinoma, Ovarian Epithelial
Female
Humans
Neoplasms, Glandular and Epithelial--enzymology
Ovarian Neoplasms--enzymology
Proto-Oncogene Proteins p21(ras)--genetics